Download full-text PDF |
Source |
---|
Dermatol Ther
December 2022
Dermatology Department, Farhat Hached University Hospital, University of Sousse, Tunisia.
Acta Parasitol
December 2018
Department of Pharmacology, University of Medicine, Avenue Avicenne 5019 Monastir, Tunisia.
Antimicrob Agents Chemother
September 2018
Laboratório de Genética e Biologia Molecular, Departamento de Biologia, Universidade Federal do Maranhão, Cidade Universitária Dom Delgado, São Luís, Maranhão, Brazil
Meglumine antimoniate (Glucantime) is a pentavalent antimonial used to treat leishmaniasis, despite its acknowledged toxic effects, such as its ability to cause oxidative damage to lipids and proteins. Recently, our group demonstrated that meglumine antimoniate causes oxidative stress-derived DNA damage. Knowing that antioxidants modulate reactive oxygen species, we evaluated the capacity of genistein and ascorbic acid for preventing genotoxicity caused by meglumine antimoniate.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!